Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Type 2 Diabetes on Outcomes Associated With Antiplatelet Drugs: A Retrospective Analysis

NCT05053828 is registered in ClinicalTrials.gov with Tabula Rasa HealthCare as lead sponsor.

NCT NCT05053828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Type 2 Diabetes on Outcomes Associated With Antiplatelet Drugs: A Retrospective Analysis
Lead sponsor
Tabula Rasa HealthCare
Phase
Observational
Overall status
Completed
Start date
September 20, 2021
Completion date
January 30, 2023
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet drugs, heart failure, myocardial infarction, type2 diabetes